Oral Abstract Session:
189. Hepatitis B and C Across the Lifespan
Friday, October 6, 2017: 2:00 PM-3:30 PM
Room: 05AB

Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Susanna Naggie, MD, MHS, Duke University Medical Center, Duke Clinical Research Institute and Michael Saag, MD, FIDSA, University of Alabama at Birmingham

2:00 PM
Performance of NS3, NS5a AND NS5b Hepatitis C Virus (HCV) Antiviral Resistance Sequencing Assays
Jamie Nutt, BS; James Grantham, BS; Marilyn Smith, PhD; Emily Smith, MS; Ashley Wedin, BS; Aaron Tyler, BS; Mauricio Miralles, MS; Steve Kleiboeker, PhD; Mark Wissel, PhD
2:15 PM
Is there Failure to Screen for Hepatitis C in Newborns Suffering from Neonatal Abstinence Syndrome?
John Myers, PhD MSPH; Michael Smith, MD, MSCE; Claudia Espinosa, MD, MSc; Charles Woods, MD, MS, FIDSA, FSHEA, FPIDS; Scott Duncan, MD, MHA
2:30 PM
The incidence of hepatocellular carcinoma is not increased in individuals with chronic hepatitis C after treatment with interferon-free regimens: an ERCHIVES study
Darrick K. Li, MD, PhD; Yanjie Ren, MS; Obaid Saikh, MD; Daniel S. Fierer, MD, FIDSA; Vincent Lo Re III, MD, MSCE; Abdul-Badi Abou-Samra, MD, PhD; Raymond T. Chung, MD; Adeel Butt, MD, MS
2:45 PM
Antiviral Treatment among Hepatitis B Virus–Infected Pregnant Women — New York City and Michigan, 2013–2015
Ruth Link-Gelles, PhD, MPH; Alaya Koneru, MPH; Julie Lazaroff, MPH; Patrick Fineis, BA; Noele Nelson, MD, PhD, MPH; Sarah Schillie, MD, MBA, MPH
3:00 PM
Treatment as prevention for hepatitis C (TraP HepC). A real-world experience from the first 12 months of a nationwide elimination program in Iceland
Magnus Gottfredsson, MD, PhD; Thorarinn Tyrfingsson, MD; Valgerdur Runarsdottir, MD; Ottar M. Bergmann, MD; Einar S. Bjornsson, MD, PhD; Birgir Johannsson, MD; Bryndis Sigurdardottir, MD; Ragnheidur H. Fridriksdottir, RN, MBA; Arthur Löve, MD, PhD; Thorvardur J. Löve, MD, PhD; Gudrun Sigmundsdottir, MD, PhD; Maria Heimisdottir, MD, PhD, MBA; Sigurdur Olafsson, MD

CME Credits: No CME credit is offered for this session.

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.